153 related articles for article (PubMed ID: 35067857)
1. Will the Public Engage with New Pharmacy Roles? Assessing Future Uptake of a Community Pharmacy Health Check Using a Discrete Choice Experiment.
Chua GN; Bond C; Porteous T; Ryan M
Patient; 2022 Jul; 15(4):473-483. PubMed ID: 35067857
[TBL] [Abstract][Full Text] [Related]
2. Managing Minor Ailments; The Public's Preferences for Attributes of Community Pharmacies. A Discrete Choice Experiment.
Porteous T; Ryan M; Bond C; Watson M; Watson V
PLoS One; 2016; 11(3):e0152257. PubMed ID: 27031588
[TBL] [Abstract][Full Text] [Related]
3. Patient preferences and willingness-to-pay for community pharmacy-led Medicare Part D consultation services: A discrete choice experiment.
Murry LT; Viyurri B; Chapman CG; Witry MJ; Kennelty KA; Nayakankuppam D; Doucette WR; Urmie J
Res Social Adm Pharm; 2023 May; 19(5):764-772. PubMed ID: 36710174
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences and cost-benefit of hypertension and hyperlipidemia collaborative management model between pharmacies and primary care in Portugal: A discrete choice experiment alongside a trial (USFarmácia®).
Costa S; Guerreiro J; Teixeira I; Helling DK; Mateus C; Pereira J
PLoS One; 2023; 18(10):e0292308. PubMed ID: 37796918
[TBL] [Abstract][Full Text] [Related]
5. Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study.
Feehan M; Walsh M; Godin J; Sundwall D; Munger MA
J Clin Pharm Ther; 2017 Dec; 42(6):738-749. PubMed ID: 28627110
[TBL] [Abstract][Full Text] [Related]
6. Patient Preferences For Specialty Pharmacy Services: A Stated Preference Discrete-Choice Experiment in China.
Hu Q; Hu H; Hu M; Yang Y; Wu Z; Zhou N
Front Public Health; 2020; 8():597389. PubMed ID: 33363089
[No Abstract] [Full Text] [Related]
7. Patient preferences for community pharmacy asthma services: a discrete choice experiment.
Naik-Panvelkar P; Armour C; Rose JM; Saini B
Pharmacoeconomics; 2012 Oct; 30(10):961-76. PubMed ID: 22823521
[TBL] [Abstract][Full Text] [Related]
8. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
[TBL] [Abstract][Full Text] [Related]
9. General public's views on pharmacy public health services: current situation and opportunities in the future.
Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
Public Health; 2015 Jun; 129(6):705-15. PubMed ID: 26008208
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
Munger MA; Walsh M; Godin J; Feehan M
Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
[TBL] [Abstract][Full Text] [Related]
11. Preferences of patients regarding community pharmacy services: A discrete choice experiment.
van de Pol JM; Heringa M; Koster ES; Bouvy ML
Health Policy; 2021 Nov; 125(11):1415-1420. PubMed ID: 34503844
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
13. Patient preferences for objective quality metrics during community pharmacy selection: A discrete choice experiment.
Patterson JA; Holdford DA; Harpe SE
Res Social Adm Pharm; 2019 Jun; 15(6):641-649. PubMed ID: 30143466
[TBL] [Abstract][Full Text] [Related]
14. Identifying Community Pharmacist Preferences For Prescribing Services in Primary Care in New Zealand: A Discrete Choice Experiment.
Raghunandan R; Howard K; Marra CA; Tordoff J; Smith A
Appl Health Econ Health Policy; 2021 Mar; 19(2):253-266. PubMed ID: 33073328
[TBL] [Abstract][Full Text] [Related]
15. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
16. Views of the Scottish general public on community pharmacy weight management services: international implications.
Weidmann AE; Cunningham S; Gray G; Hansford D; Bermano G; Stewart D
Int J Clin Pharm; 2012 Apr; 34(2):389-97. PubMed ID: 22382887
[TBL] [Abstract][Full Text] [Related]
17. Medicine-related services in community pharmacy: public preferences for pharmacy attributes and promotional methods and comparison with pharmacists' perceptions.
Gammie SM; Rodgers RM; Loo RL; Corlett SA; Krska J
Patient Prefer Adherence; 2016; 10():2297-2307. PubMed ID: 27877021
[TBL] [Abstract][Full Text] [Related]
18. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
[TBL] [Abstract][Full Text] [Related]
19. How does the general public balance convenience and cognitive pharmaceutical services in community pharmacy practice.
van de Pol JM; van Dijk L; Koster ES; de Jong J; Bouvy ML
Res Social Adm Pharm; 2021 Mar; 17(3):606-612. PubMed ID: 32534955
[TBL] [Abstract][Full Text] [Related]
20. The Inverse Care Law might not apply to preventative health services in community pharmacy.
Zonneveld S; Versace VL; Krass I; Clark RA; Shih S; Detert Oude Weme S; Mc Namara KP
Res Social Adm Pharm; 2021 May; 17(5):875-884. PubMed ID: 33092979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
